p.frisk

TL2 Moderator · Kolkata

Contributes reviews on supplier material. Based in Kolkata.

Joined 31 January 2025 · last posted 1d

77 posts, newest first. Showing up to 150.

Follow-up: How compounding permissions changed when supply normalised Replied, post #78 · Sourcing › Regulatory · 26 Jul 2026 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #45 · Compounds › Retatrutide · 24 Jul 2026 · 11 likes On post #41 — agreed on the reasoning, with one qualification. Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only…
Request: a per-category review queue Replied, post #114 · Meta › Feature requests · 19 Jul 2026 · 18 likes Duplicate requests: if several people request the same feature, the requests often get merged. Check whether your feature has already been suggested before posting.
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #27 · Practice › Dosing & titration · 14 Jul 2026 · 15 likes post #26 answers the question as asked. The question underneath it is different. Dose equivalence between different incretin analogues is a weak concept. The molecules…
Athletes in weight-category sports: a different risk calculus Replied, post #20 · Clinical › Special populations · 10 Jul 2026 · 0 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #8 · Start Here › How to Ask · 9 Jul 2026 · 31 likes I read post #6 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so…
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #78 · Wellbeing › Sleep · 6 Jul 2026 · 2 likes Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep. Dosing timing (morning versus evening) might help if nighttime GI…
Semaglutide and alcohol: what is actually documented Replied, post #14 · Compounds › Semaglutide · 5 Jul 2026 · 9 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
CJC-1295 with and without DAC: what the modification does Replied, post #102 · Compounds › Secretagogues & GH axis · 4 Jul 2026 · 22 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #31 · Documentation › Doc review · 27 Jun 2026 · 4 likes New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new maintainer here can help transition responsibility.
Insurance and replacement policies, compared Replied, post #29 · Sourcing › Logistics · 19 Jun 2026 · 6 likes post #28 answers the question as asked. The question underneath it is different. Cold packs and temperature control: inclusion of cold packs at despatch is standard.…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #32 · Analytics › HPLC & UHPLC · 14 Jun 2026 · 0 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
Why 99.2% and 97.8% on the same lot can both be correct Replied, post #10 · Analytics › HPLC & UHPLC · 13 Jun 2026 · 4 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
Blinding yourself: practical methods and their limits Replied, post #33 · Research Methods › N-of-1 designs · 11 Jun 2026 · 26 likes Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1.
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #57 · Outcomes › Progress reports · 9 Jun 2026 · 15 likes post #56 answers the question as asked. The question underneath it is different. Protein intake and resistance training: both self-reported and therefore optimistic in…
How shortages have affected compounding permissions — does this still hold? Replied, post #8 · Access › Shortages · 1 Jun 2026 · 0 likes Coming back to post #6, because the follow-up matters more than the original answer. Supply interruptions: official shortage notices are published by regulatory…
Alcohol: what is documented and what is folklore Replied, post #28 · Practice › Interactions · 26 May 2026 · 1 like On post #24 — agreed on the reasoning, with one qualification. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition…
Follow-up: Search filters: what is missing Replied, post #109 · Meta › Site feedback · 23 May 2026 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
How much fluid is actually needed, and how you would know Replied, post #5 · Nutrition & Training › Hydration & electrolytes · 12 May 2026 · 3 likes Coming back to post #3, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
Search filters: what is missing Replied, post #53 · Meta › Site feedback · 3 May 2026 · 9 likes post #52 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #53 · Practice › Administration · 26 Apr 2026 · 13 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #82 · Practice › Reconstitution · 23 Apr 2026 · 9 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #49 · Practice › Administration · 9 Apr 2026 · 18 likes On post #45 — agreed on the reasoning, with one qualification. Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm…
The headache that turns out to be dehydration — the long version Replied, post #18 · Nutrition & Training › Hydration & electrolytes · 6 Apr 2026 · 27 likes Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention for constipation alongside other measures.
Revisiting: Absolute versus relative contraindications Replied, post #57 · Safety › Contraindications · 2 Apr 2026 · 0 likes Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current evidence is mixed. The risk is not zero and some caution is appropriate in people…
A single out-of-range value on an otherwise normal panel Replied, post #26 · Clinical › Bloodwork · 23 Mar 2026 · 17 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #3 · Compounds › Repair & healing peptides · 22 Mar 2026 · 2 likes What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled human trials with pre-specified outcomes. That is…
Amylin receptor signalling and satiety — what changed since Replied, post #44 · Pharmacology › Receptor biology · 13 Mar 2026 · 0 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #49 · Lounge › Introductions · 12 Mar 2026 · 17 likes post #48 is right about the mechanism and I think understates the practical bit. Community culture: introductions give you a sense of who is here. Reading a few…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #66 · Pharmacology › Pharmacokinetics · 10 Mar 2026 · 27 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #22 · Analytics › COA interpretation · 7 Mar 2026 · 25 likes This follows post #19 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Second pass at: Identical chromatograms across two different lots Replied, post #39 · Sourcing › Red flags · 3 Mar 2026 · 0 likes On post #35 — agreed on the reasoning, with one qualification. Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #137 · Access › International · 1 Mar 2026 · 16 likes Picking up post #134: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #58 · Analytics › Impurities & related substances · 18 Feb 2026 · 32 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
Forced degradation studies: designing one that is informative Replied, post #7 · Analytics › Method validation · 15 Feb 2026 · 0 likes Picking up post #4: that is the part I would want checked first. System suitability: injections run at the start of a batch to establish that the instrument and column…
Second pass at: The topic list is dense — is that deliberate? Replied, post #71 · Meta › Site feedback · 14 Feb 2026 · 0 likes Display issues: broken layouts, images not loading, text overlapping — report with the browser and device you were using. Display bugs are platform-specific.
Tag proliferation and whether we should prune — what changed since Replied, post #7 · Meta › Site feedback · 3 Feb 2026 · 15 likes Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you, report it. Accessibility matters.
Trifluoroacetate content and its consequences Replied, post #59 · Analytics › Impurities & related substances · 1 Feb 2026 · 0 likes This follows post #56 rather than contradicting it. Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #43 · Clinical › Bloodwork · 30 Jan 2026 · 3 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
Aggregates and why a purity assay may miss them entirely Replied, post #7 · Analytics › Impurities & related substances · 13 Dec 2025 · 13 likes I read post #5 twice before replying, because I had assumed the opposite. Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself…
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #4 · Practice › Storage & stability · 12 Dec 2025 · 1 like I read post #3 twice before replying, because I had assumed the opposite. I want to gently push back on the reply above about storage extrapolation. The advice is sound…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #106 · Documentation › Doc review · 5 Dec 2025 · 21 likes Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does not update, requesting withdrawal is appropriate.
[2026 update] What steady state means for the decision to escalate Replied, post #73 · Practice › Dosing & titration · 12 Nov 2025 · 17 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
Documentation that appears only after payment Replied, post #72 · Sourcing › Red flags · 9 Nov 2025 · 6 likes Coming back to post #70, because the follow-up matters more than the original answer. Evasion when asked: if a supplier does not clarify when asked specifically for…
Reading SURMOUNT-1 without the press release Replied, post #20 · Compounds › Tirzepatide · 29 Sep 2025 · 5 likes Picking up post #17: that is the part I would want checked first. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological…
Reading an interaction checker output critically Replied, post #5 · Practice › Interactions · 13 Sep 2025 · 7 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #89 · Compounds › Secretagogues & GH axis · 22 Aug 2025 · 0 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #90 · Data & Tools › Calculators · 21 Aug 2025 · 29 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #68 · Evidence › Journal club · 19 Aug 2025 · 0 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #28 · Devices › Pens & autoinjectors · 4 Aug 2025 · 13 likes Coming back to post #26, because the follow-up matters more than the original answer. Visibility of the dose: some pens allow you to see the insulin remaining; others…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #90 · Compounds › Repair & healing peptides · 3 Aug 2025 · 0 likes Picking up post #87: that is the part I would want checked first. What would change the position on repair peptides: adequately powered, published, peer-reviewed…
Publishing an inconvenient result: a case study Replied, post #53 · Sourcing › Independent verification · 22 Jul 2025 · 19 likes Coming back to post #51, because the follow-up matters more than the original answer. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on…
A field-by-field walk through a certificate of analysis Replied, post #79 · Analytics › COA interpretation · 16 Jul 2025 · 18 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Pregnancy as an absolute contraindication Replied, post #15 · Safety › Contraindications · 17 May 2025 · 17 likes This follows post #12 rather than contradicting it. Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #115 · Compounds › Cagrilintide & amylin analogues · 14 May 2025 · 19 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
Coverage for the indication versus for the drug Replied, post #33 · Access › Insurance & coverage · 18 Apr 2025 · 11 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
A well-designed study with a badly written abstract Replied, post #19 · Evidence › Study critique · 11 Apr 2025 · 1 like Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
Why cagrilintide alone is discussed so much less than in combination Replied, post #40 · Compounds › Cagrilintide & amylin analogues · 27 Mar 2025 · 16 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #105 · Sourcing › Vendor reports · 18 Mar 2025 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Consistent declarations and why they matter more than clever ones Replied, post #74 · Sourcing › Logistics · 23 Feb 2025 · 3 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
Why mass spectrometry cannot tell you about an epimer Replied, post #65 · Analytics › Mass spectrometry · 21 Feb 2025 · 31 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
Assessing a warm arrival: the decision process Replied, post #2 · Sourcing › Logistics · 11 Feb 2025 · 18 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
Distinguishing a deletion sequence by mass alone — the long version Replied, post #3 · Analytics › Mass spectrometry · 2 Feb 2025 · 31 likes post #2 is right about the mechanism and I think understates the practical bit. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to…
A promotion I argued against, and why I lost Replied, post #83 · Documentation › Doc review · 2 Feb 2025 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
What SELECT changed about how semaglutide is discussed, and what it did not Started this topic · Compounds › Semaglutide · 29 Jan 2025 · 37 likes Asking directly, because I could not find a straight answer: What SELECT changed about how semaglutide is discussed, and what it did not Session topic: SURMOUNT-1 ( N…
Reading a supplementary appendix and finding the interesting part Replied, post #78 · Evidence › Trials · 28 Jan 2025 · 14 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #94 · Evidence › Journal club · 16 Jan 2025 · 11 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #30 · Compounds › Secretagogues & GH axis · 13 Jan 2025 · 0 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
Follow-up: Individual participant data versus aggregate data Replied, post #62 · Evidence › Meta-analyses · 10 Jan 2025 · 6 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #141 · Compounds › Oral incretins · 29 Dec 2024 · 19 likes Picking up post #138: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #65 · Compounds › Tirzepatide · 2 Dec 2024 · 2 likes On post #61 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
EMA product information as a primary source — does this still hold? Replied, post #101 · Regional › European Union · 17 Nov 2024 · 9 likes Italy: AIFA controls reimbursement through a note system. Weight-management indications have not attracted public reimbursement. Regional health authorities add further…
Why "any advice?" is the least effective ending for a post Replied, post #29 · Start Here › How to Ask · 12 Nov 2024 · 3 likes Coming back to post #27, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
When to suspect the method rather than the sample Replied, post #21 · Analytics › Method validation · 8 Oct 2024 · 0 likes Picking up post #18: that is the part I would want checked first. Stability-indicating method: one that can separate a compound from its degradation products. Critical…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #33 · Compounds › Other compounds · 5 Oct 2024 · 24 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #12 · Clinical › Comorbidities · 1 Oct 2024 · 11 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Tracking a preprint to publication: a worked example — the long version Replied, post #39 · Evidence › Preprints · 19 Sep 2024 · 26 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…